Placebo-controlled trials are the gold standard for testing whether a supplement’s effects are real or driven by expectation. Maca has been tested against placebo in a number of small randomized trials. Here is an honest look at where maca outperformed placebo and where it did not.
Where Maca Outperformed Placebo
The clearest placebo-controlled finding for maca is a modest improvement in self-reported libido. In the trial most often cited for it, the gain over placebo emerged at week 8 and held through week 12, and a regression analysis showed it was not carried by testosterone, estradiol, or mood[1]. That detail matters for this comparison: whatever separated maca from placebo there, it was not a hormonal effect.
Across the wider literature the win is not unanimous, however. Of the four randomised trials assessed in one review, all but one beat placebo on desire or dysfunction, though the review judged the evidence limited[2]. Menopausal anxiety and depression subscales are the second outcome where maca has repeatedly separated from placebo[3][4].
Semen quality is the outcome where the placebo comparison is least kind to maca. The largest single randomised comparison separated from placebo on sperm concentration and on nothing else; motility, semen volume and morphology all came back indistinguishable[5]. Pooling five randomised trials then erased even the concentration result, leaving a weighted mean difference of 2.22 with a confidence interval running from -2.94 to 7.37, comfortably across zero[6]. The honest reading of this outcome is not that maca needs more research to confirm a benefit. It is that maca has not so far beaten placebo here at all.
Where Results Were Mixed or Not Significant
Not every maca trial has shown a clear advantage over placebo. Vasomotor symptoms during menopause (hot flashes, night sweats) have shown inconsistent results, with some trials reporting benefit and others showing no meaningful difference from placebo. The review covering menopausal symptoms reached the same limited verdict[7].
Energy and general fatigue outcomes have also produced mixed results across trials, with the placebo response in these categories often being substantial, which makes it harder to detect a true drug or supplement effect. One of the larger trials, at 175 participants, did come out ahead of placebo on mood, energy and health-related quality of life over 12 weeks[8], so this is an area where trials disagree rather than one where maca has clearly failed.
Why Placebo Response Is Especially Relevant for Maca
Subjective outcomes like libido, mood, and energy are particularly susceptible to placebo response, since expectation and belief can genuinely influence how people rate these experiences. This is exactly why placebo-controlled design matters so much for a supplement like maca, and why single-arm or open-label studies (which some early maca research relied on) are less reliable than the newer double-blind randomized trials.
Frequently Asked Questions
Does maca beat placebo for every outcome studied?
No. Maca has shown a fairly consistent advantage over placebo for self-reported libido in several trials, but results for hot flashes, general energy and semen quality have been mixed. On semen quality specifically, the pooled randomised evidence did not separate maca from placebo[6].
Why does placebo response matter so much in supplement research?
Subjective outcomes like mood, libido, and energy are strongly influenced by expectation. Well-designed placebo-controlled trials help separate a supplement’s real effect from the effect of simply believing it will work.
Are newer maca trials better designed than older ones?
Generally yes. Newer trials have moved toward double-blind, randomized, placebo-controlled designs, which produce more reliable evidence than the open-label studies common in earlier maca research.
References
- Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men. Andrologia, 2002
- Maca (L. meyenii) for improving sexual function: a systematic review. BMC complementary and alternative medicine, 2010
- Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause (New York, N.Y.), 2008
- Maca reduces blood pressure and depression, in a pilot study in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2015
- Does Lepidium meyenii (Maca) improve seminal quality?. Andrologia, 2020
- Maca (Lepidium meyenii Walp.) on semen quality parameters: A systematic review and meta-analysis. Frontiers in pharmacology, 2022
- Maca (Lepidium meyenii) for treatment of menopausal symptoms: A systematic review. Maturitas, 2011
- Acceptability, Safety, and Efficacy of Oral Administration of Extracts of Black or Red Maca (Lepidium meyenii) in Adult Human Subjects: A Randomized, Double-Blind, Placebo-Controlled Study. Pharmaceuticals (Basel, Switzerland), 2016
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.



